Prevalence and incidence of Trichomonas vaginalis infections in women participating in a clinical trial in Durban, South Africa

Sexually Transmitted Infections

Volumn 89, Issue 6, 2013, Pages 519-522

  Naidoo, Sarita ^a   Wand, Handan ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEXUAL BEHAVIOR; SOUTH AFRICA; TRICHOMONIASIS; UTERINE CERVIX CAP;

AFRICA; CLINICAL TRIALS; TESTING; TRICHOMONAS; WOMEN;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; YOUNG ADULT;

EID: 84884525668     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050984     Document Type: Article

References (24)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections, overviews and estimates 2001. Geneva, Switzerland: WHO, 2001.
2. Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998;11:300-17. (Pubitemid 28197355)
3. Yadav M, Gupta I, Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunol 2005;27:461-7. (Pubitemid 41640942)
4. Wilkinson D, Ndovela N, Harrison A, et al. Family planning services in developing countries: an opportunity to treat asymptomatic and unrecognized genital tract infections? Genitourin Med 1997;73:558-60. (Pubitemid 28064703)
5. Fichorova RN. Impact of T. vaginalis infection on innate immune response a reproductive outcome. J Reprod Immunol 2009;83:185-9.
6. McClelland RS. Trichomonas vaginalis infection: can we afford to do nothing? J Infect Dis 2008;197:487-9. (Pubitemid 351321524)
7. Mavedzenge SN, Van Der Pol B, Cheng H, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis 2010;37:460-7.
8. Stringer E, Read JS, Hoffman I, et al. Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J 2010;100:58-64.
9. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev 2009;22:37-45.
10. Singh BN, Lucas JJ, Fichorova RN. Trichomonas vaginalis: Pathobiology and Pathogenesis. Emerging Protozoan Pathogens. London, UK: Taylor &Francis Group, 2007;411-55.
11. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect Sex Reprod Health 2004;36:6-10. (Pubitemid 38258322)
12. Cudmore SL, Garber GE. Prevention or treatment: The benefits of Trichomonas vaginalis vaccine. J Infect Public Health 2010;3:47-53.
13. Johnson LF, Dorrington RE, Bradshaw D, et al. The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Healthcare 2011;2:13-20.
14. White RG, Moodley P, McGrath N, et al. Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa. Sex Transm Infect 2008;84:528-34.
15. Leon SR, Konda KA, Bernstein KT, et al. Trichomonas vaginalis infection and associated risk factors in a socially-marginalized female population in coastal Peru. Infect Dis Obstet Gynecol 2009;1155:1-6.
16. Helms DJ, Mosure DJ, Metcalf CA, et al. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm Dis 2008;35:484-8. (Pubitemid 351670550)
17. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomized controlled trial. Lancet 2007;370:251-61. (Pubitemid 47069513)
18. Wand H, Ramjee G. Combined impact of sexual risk behaviours for HIV seroconversion among women in Durban, South Africa: implications for prevention policy and planning. Aids Behav 2011;15:479-86.
19. Kissinger P, Secor WE, Leichliter JS, et al. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis 2008;46:994-9. (Pubitemid 351589863)
20. Rosenberg MJ, Davidson AJ, Chen JH, et al. Barrier contraceptives and sexually transmitted diseases in women: A comparison of female-dependent methods and condoms. Am J Public Health 1992;82:669-74.
21. Ordóñez CE, Marconi VC. Understanding HIV risk behavior from a sociocultural perspective. J AIDS Clinic Res 2012;3:e108.
22. Meyer-Weitz A, Reddy P, Weijts W, et al. The socio-cultural contexts of sexually transmitted diseases in South Africa: implications for health education programmes. AIDS Care 1998;10:39-55.
23. Harrison A, Lurie M, Wilkinson N. Exploring partner communication and patterns of sexual networking: qualitative research to improve management of sexually transmitted diseases. Health Transit Rev 1997;7:103-7.
24. Ramjee G, Wand H, Whitaker C, et al. HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in Kwazuu-Natal, South Africa. AIDS Behav 2012;16:2062-71.